Progress and challenges in colorectal cancer screening and surveillance
- PMID: 20167216
- DOI: 10.1053/j.gastro.2010.02.006
Progress and challenges in colorectal cancer screening and surveillance
Abstract
Colorectal cancer is a leading cause of cancer death throughout the world. There is evidence that screening of average-risk individuals can result in mortality reduction with early cancer detection and cancer prevention by detection and removal of cancer precursor lesions. The optimal form of screening is not clear. Fecal screening tests can be performed at home at low initial cost, but current versions lack high sensitivity for cancer precursor lesions, and tests need to be repeated at regular intervals. Adherence to repeat testing for negative tests and referral for colonoscopy for positive tests are important elements of program effectiveness. Structural examinations of the colon are more invasive and may result in detection of both early cancer and cancer precursor lesions. Every screening program has advantages and limitations, but each program ultimately depends on quality and patient adherence.
Similar articles
-
Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S198-204. doi: 10.1111/j.1440-1746.2008.05556.x. J Gastroenterol Hepatol. 2008. PMID: 19120898
-
Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.Asian Pac J Cancer Prev. 2012;13(5):1761-6. doi: 10.7314/apjcp.2012.13.5.1761. Asian Pac J Cancer Prev. 2012. PMID: 22901118
-
Colon cancer screening and surveillance controversies.Curr Opin Gastroenterol. 2009 Sep;25(5):422-7. doi: 10.1097/MOG.0b013e32832d1e2a. Curr Opin Gastroenterol. 2009. PMID: 19465849 Review.
-
Guidelines for colorectal cancer screening--a puzzle of tests and strategies.Acta Clin Belg. 2010 Nov-Dec;65(6):433-6. doi: 10.1179/acb.2010.65.6.012. Acta Clin Belg. 2010. PMID: 21268961 Review.
-
Screening and surveillance for colorectal carcinoma.Hematol Oncol Clin North Am. 1997 Aug;11(4):579-608. doi: 10.1016/s0889-8588(05)70452-4. Hematol Oncol Clin North Am. 1997. PMID: 9257147 Review.
Cited by
-
Cancer Screening Rates Among Asian Americans: A Cross-Sectional Secondary Data Analysis Study.Cancer Control. 2023 Jan-Dec;30:10732748231202462. doi: 10.1177/10732748231202462. Cancer Control. 2023. PMID: 37728218 Free PMC article.
-
Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia.Gut. 2023 Jul;72(7):1240-1254. doi: 10.1136/gutjnl-2023-329429. Epub 2023 Apr 5. Gut. 2023. PMID: 37019620 Free PMC article.
-
Netrin-4: Focus on Its Role in Axon Guidance, Tissue Stability, Angiogenesis and Tumors.Cell Mol Neurobiol. 2023 Jul;43(5):1663-1683. doi: 10.1007/s10571-022-01279-4. Epub 2022 Nov 9. Cell Mol Neurobiol. 2023. PMID: 36350538 Review.
-
CircHADHA-augmented autophagy suppresses tumor growth of colon cancer by regulating autophagy-related gene via miR-361.Front Oncol. 2022 Oct 13;12:937209. doi: 10.3389/fonc.2022.937209. eCollection 2022. Front Oncol. 2022. PMID: 36313671 Free PMC article.
-
Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance.Front Cell Dev Biol. 2021 May 24;9:660924. doi: 10.3389/fcell.2021.660924. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34150757 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
